rss
Heart Asia 6:41-45 doi:10.1136/heartasia-2013-010478
  • Review in cardiovascular technology

An update on coronary bypass graft intervention

  1. Debabrata Dash
  1. Correspondence to Dr Debabrata Dash, Department of Cardiology, Fortis Raheja Hospital, Cumballa Hill Hospital, Mumbai, Maharashtra 400016, India; dr_dash2003{at}yahoo.com
  • Received 9 November 2013
  • Revised 23 December 2013
  • Accepted 22 January 2014

Abstract

Coronary artery bypass grafting (CABG) remains one of the most common surgical procedures. In spite of great advancements like arterial grafts and off-pump bypass procedure, recurrent ischaemia may ensue with the lesions of the graft. Early postoperative ischaemia (<30 days) is due to graft occlusion or stenosis, and percutaneous coronary intervention (PCI) is frequently feasible. Late postoperative ischaemia (>3 years) is most often due to a saphenous vein graft (SVG) lesion. Multiple diseased grafts, reduced left ventricular function, and available arterial conduits favour repeat CABG, whereas, a patent left internal mammary artery to left anterior descending favours PCI. Embolic protection reduces atheroembolic myocardial infarction during PCI of SVG and should be routinely used in treatment of SVG lesions. A variety of vasodilators may reduce the risk of or mitigate the consequences of no-reflow. Drug-eluting stents reduce restenosis in SVG grafts, and have become the default strategy for many interventionalists.